Research: Adult Stem Cells
Balyasnikova, I. V., Prasol, M. S., Ferguson, S. D., Han, Y., Ahmed, A. U., Gutova, M., … & Aboody, K. S. (2013). Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors. Molecular Therapy.
Cox, C. S., Hetz, R. A., Liao, G. P., Aertker, B. M., Ewing‐Cobbs, L., Juranek, J., … & Dash, P. K. (2016). Treatment of severe adult traumatic brain injury using bone marrow mononuclear cells. Stem Cells.
Danielyan, L., Schäfer, R., von Ameln-Mayerhofer, A., Buadze, M., Geisler, J., Klopfer, T., … & Buniatian, G. H. (2009). Intranasal delivery of cells to the brain. European journal of cell biology, 88(6), 315-324.
Danielyan, L., Beer-Hammer, S., Stolzing, A., Schäfer, R., Siegel, G., Fabian, C., … & Novakovic, A. (2014). Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer’s and Parkinson’s disease. Cell transplantation,23(Supplement 1), S123-S139.
Danielyan, L., Schäfer, R., von Ameln-Mayerhofer, A., Bernhard, F., Verleysdonk, S., Buadze, M., … & Koehle, C. (2011). Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation research, 14(1), 3-16.
Filidou E, Kandilogiannakis L, Tarapatzi G, Spathakis M, Su C, Rai A, Greening DW, Arvanitidis K, Paspaliaris V, Kolios G. A Simplified and Effective Approach for the Isolation of Small Pluripotent Stem Cells Derived from Human Peripheral Blood. Biomedicines. 2023; 11(3):787. https://doi.org/10.3390/biomedicines11030787
Fransson, M., Piras, E., Burman, J., Nilsson, B., Essand, M., Lu, B., … & Loskog, A. S. (2012). CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery. Journal of neuroinflammation, 9(1), 112.
Gargiulo, C., Pham, V. H., Nguyen, K. C. D., Trieu, V. L. H., & Duy, T. H. (2016). Autologous Peripheral Blood Stem Cells Increase the Telomere Length in Patient: A Case Report of 13 Patients. J Stem Cell Res Ther, 6(352), 2.
Hanson, L. R., & Frey, W. H. (2008). Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC neuroscience, 9(Suppl 3), S5.
Johnson, V. E., Stewart, W., & Smith, D. H. (2010). Traumatic brain injury and amyloid-β pathology: a link to Alzheimer’s disease? Nature Reviews. Neuroscience, 11(5), 361–370. https://doi.org/10.1038/nrn2808.
Liao, G. P., Harting, M. T., Hetz, R. A., Walker, P. A., Shah, S. K., Corkins, C. J., … & Tsao, K. (2015). Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children. Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 16(3), 245.
O’Neill, D. W., Jiang, Y., Leary, E., Yavanian, G., Eminli, S., & Marasco, W. A. (2012). A Lin-CD45-CD34+ Population of Extracellular Vesicles in Human Blood That Mimics Very Small Embryonic-Like Stem Cells (VSELs) by Flow Cytometry.
Ratajczak, M. Z., Zuba-Surma, E. K., Wysoczynski, M., Ratajczak, J., & Kucia, M. (2008). Very small embryonic-like stem cells: characterization, developmental origin, and biological significance. Experimental hematology, 36(6), 742-751.
Roggendorf, W., Opitz, H., & Schuppan, D. (1988). Altered expression of collagen type VI in brain vessels of patients with chronic hypertension. Acta Neuropathologica Acta Neuropathol, 77(1), 55-60.
Sovalat, H., Scrofani, M., Eidenschenk, A., & Hénon, P. (2015). Human very small embryonic-like stem cells are present in normal peripheral blood of young, middle-aged, and aged subjects. Stem cells international, 2016.
University of Illinois College of Agricultural, Consumer and Environmental Sciences. (2018, October 17). Stem cell proliferation is controlled directly by nervous system, scientists find. ScienceDaily. Retrieved November 2, 2018 from www.sciencedaily.com/releases/2018/10/181017141033.htm
van Velthoven, C. T., Kavelaars, A., van Bel, F., & Heijnen, C. J. (2010). Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. Pediatric research, 68, 419-422.
Wei, N., Yu, S. P., Gu, X., Taylor, T. M., Song, D., Liu, X. F., & Wei, L. (2013). Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice. Cell transplantation,22(6), 977-991.
William, H. F. I., Danielyan, L., & Gleiter, C. H. (2016). U.S. Patent No. 9,445,991. Washington, DC: U.S. Patent and Trademark Office.
Zhang, J., Jiang, R., Liu, L., Watkins, T., Zhang, F., & Dong, J. (2012). Traumatic brain injury-associated coagulopathy. Journal of Neurotrauma, 29(17), 2597-2605. doi: 10.1089/neu.2012.2348
Platelet Rich Plasma
Balyasnikova, I. V., Prasol, M. S., Ferguson, S. D., Han, Y., Ahmed, A. U., Gutova, M., … & Aboody, K. S. (2013). Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors. Molecular Therapy.
Cox, C. S., Hetz, R. A., Liao, G. P., Aertker, B. M., Ewing‐Cobbs, L., Juranek, J., … & Dash, P. K. (2016). Treatment of severe adult traumatic brain injury using bone marrow mononuclear cells. Stem Cells.
Danielyan, L., Schäfer, R., von Ameln-Mayerhofer, A., Buadze, M., Geisler, J., Klopfer, T., … & Buniatian, G. H. (2009). Intranasal delivery of cells to the brain. European journal of cell biology, 88(6), 315-324.
Danielyan, L., Beer-Hammer, S., Stolzing, A., Schäfer, R., Siegel, G., Fabian, C., … & Novakovic, A. (2014). Intranasal delivery of bone marrow-derived mesenchymal stem cells, macrophages, and microglia to the brain in mouse models of Alzheimer’s and Parkinson’s disease. Cell transplantation,23(Supplement 1), S123-S139.
Danielyan, L., Schäfer, R., von Ameln-Mayerhofer, A., Bernhard, F., Verleysdonk, S., Buadze, M., … & Koehle, C. (2011). Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation research, 14(1), 3-16.
Filidou E, Kandilogiannakis L, Tarapatzi G, Spathakis M, Su C, Rai A, Greening DW, Arvanitidis K, Paspaliaris V, Kolios G. A Simplified and Effective Approach for the Isolation of Small Pluripotent Stem Cells Derived from Human Peripheral Blood. Biomedicines. 2023; 11(3):787. https://doi.org/10.3390/biomedicines11030787
Fransson, M., Piras, E., Burman, J., Nilsson, B., Essand, M., Lu, B., … & Loskog, A. S. (2012). CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery. Journal of neuroinflammation, 9(1), 112.
Gargiulo, C., Pham, V. H., Nguyen, K. C. D., Trieu, V. L. H., & Duy, T. H. (2016). Autologous Peripheral Blood Stem Cells Increase the Telomere Length in Patient: A Case Report of 13 Patients. J Stem Cell Res Ther, 6(352), 2.
Hanson, L. R., & Frey, W. H. (2008). Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease. BMC neuroscience, 9(Suppl 3), S5.
Johnson, V. E., Stewart, W., & Smith, D. H. (2010). Traumatic brain injury and amyloid-β pathology: a link to Alzheimer’s disease? Nature Reviews. Neuroscience, 11(5), 361–370. https://doi.org/10.1038/nrn2808.
Liao, G. P., Harting, M. T., Hetz, R. A., Walker, P. A., Shah, S. K., Corkins, C. J., … & Tsao, K. (2015). Autologous bone marrow mononuclear cells reduce therapeutic intensity for severe traumatic brain injury in children. Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 16(3), 245.
O’Neill, D. W., Jiang, Y., Leary, E., Yavanian, G., Eminli, S., & Marasco, W. A. (2012). A Lin-CD45-CD34+ Population of Extracellular Vesicles in Human Blood That Mimics Very Small Embryonic-Like Stem Cells (VSELs) by Flow Cytometry.
Ratajczak, M. Z., Zuba-Surma, E. K., Wysoczynski, M., Ratajczak, J., & Kucia, M. (2008). Very small embryonic-like stem cells: characterization, developmental origin, and biological significance. Experimental hematology, 36(6), 742-751.
Roggendorf, W., Opitz, H., & Schuppan, D. (1988). Altered expression of collagen type VI in brain vessels of patients with chronic hypertension. Acta Neuropathologica Acta Neuropathol, 77(1), 55-60.
Sovalat, H., Scrofani, M., Eidenschenk, A., & Hénon, P. (2015). Human very small embryonic-like stem cells are present in normal peripheral blood of young, middle-aged, and aged subjects. Stem cells international, 2016.
University of Illinois College of Agricultural, Consumer and Environmental Sciences. (2018, October 17). Stem cell proliferation is controlled directly by nervous system, scientists find. ScienceDaily. Retrieved November 2, 2018 from www.sciencedaily.com/releases/2018/10/181017141033.htm
van Velthoven, C. T., Kavelaars, A., van Bel, F., & Heijnen, C. J. (2010). Nasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage. Pediatric research, 68, 419-422.
Wei, N., Yu, S. P., Gu, X., Taylor, T. M., Song, D., Liu, X. F., & Wei, L. (2013). Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice. Cell transplantation,22(6), 977-991.
William, H. F. I., Danielyan, L., & Gleiter, C. H. (2016). U.S. Patent No. 9,445,991. Washington, DC: U.S. Patent and Trademark Office.
Zhang, J., Jiang, R., Liu, L., Watkins, T., Zhang, F., & Dong, J. (2012). Traumatic brain injury-associated coagulopathy. Journal of Neurotrauma, 29(17), 2597-2605. doi: 10.1089/neu.2012.2348
Prolotherapy
Alderman, D. (2015). The New Age of Prolotherapy. Practical Pain Management.
Andreula, C. F., Simonetti, L., de Santis, F., Agati, R., Ricci, R., & Leonardi, M. (2003). Minimally Invasive Oxygen-Ozone Therapy for Lumbar Disk Herniation. AJNR American Journal Neuroradiology, 24, 996-1000.
Applied Ozone Systems. Medical ozone oxygen therapy references. Retrieved from https://www.appliedozone.com/references.html.
Bocci, V. (1999). Biological and clinical effects of ozone. Has ozone therapy a future in medicine? British Journal of Biomedical Science. 56(4), 270-279.
Bocci, V. (2011). OZONE A new medical drug. Dordrecht, The Netherlands: Springer.
Boyles, S. (2009). Ozone may help herniated disc pain. WebMD. Retrieved from https://www.webmd.com/back-pain/news/20090309/ozone-may-help-herniated-disc-pain.
D’Erme M, Scarchilli A, Artale A, Pasquali Lasagni, M. (1998). Ozone therapy in lumbar sciatic pain. Raidol Med. 95, 1-2.
Elvis, A. M., & Ekta, J. S. (2011). Ozone therapy: A clinical review. Journal of Natural Science, Biology, and Medicine, 2(1), 66–70. https://doi.org/10.4103/0976-9668.82319.
Hashemi M, et al. (2015). The effects of prolotherapy aith hypertonic dextrose versus prolozone (intraarticular ozone) in patients with knee osteoarthritis. Anesth Pain Med. 5(5). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644302/.
Heckel, A. (n.d.). Prolotherapy claims to treat sprains and pains without surgery or pills. Retrieved March 02, 2016, from https://www.dailycamera.com/ci_21263857/prolotherapy-claims-treat-sprains-and-pains-without-surgery.
Ongley, M., Dorman, T., Klein, R., Eek, B., & Hubert, L. (1987). A new approach to the treatment of chronic low back pain. The Lancet, 330(8551), 143-146.
Phend, C. (2009). Ozone shots as effective as surgery for back pain. Medpage Today. Retrieved from https://www.medpagetoday.com/MeetingCoverage/SIR/13206.
Prolotherapy for chronic ankle pain. (n.d.). Retrieved March 11, 2016, from https://www.getprolo.com/prolotherapy-chronic-ankle-pain/
Rabago, D., Slattengren, A., & Zgierska, A. (2010). Prolotherapy in Primary Care PracticeProlotherapy in Primary Care Practice. National Institute of Health. 37(1), 65-80.
Re, L., Mawsouf, M., Menendez, S., Leon, O., Sanchez, G., Hernandez., F. (2008). Ozone therapy: Clinical and basic evidence of its therapeutic potential. Archives of Medical Research. 39(1), 17-26.
Sagai, M., & Bocci, V. (2011). Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress? Medical Gas Research, 1, 29. https://doi.org/10.1186/2045-9912-1-29
Work, H. I., & FAQs, P. Prolotherapy for Back Pain Treatment.
Yildirim, C., Akmaz, I., Sahin, O., & Keklikci, K. (2011). Simple calcaneal bone cysts. J Bone Joint Surg Br, 93-B(12), 1626-1631.
Prolozone
Andreula, C. F., Simonetti, L., de Santis, F., Agati, R., Ricci, R., & Leonardi, M. (2003). Minimally Invasive Oxygen-Ozone Therapy for Lumbar Disk Herniation. AJNR American Journal Neuroradiology, 24, 996-1000.
Bocci, V., Zanardi, I., & Travagli, V. (2011). Oxygen/ozone as a medical gas mixture. A critical evaluation of the various methods clarifies positive and negative aspects.Medical gas research, 1(1), 1-9.
Boyles, S. (2009). Ozone may help herniated disc pain. WebMD. Retrieved from https://www.webmd.com/back-pain/news/20090309/ozone-may-help-herniated-disc-pain.
D’Erme M, Scarchilli A, Artale A, Pasquali Lasagni, M. (1998). Ozone therapy in lumbar sciatic pain. Raidol Med. 95, 1-2.
Hashemi M, et al. (2015). The effects of prolotherapy aith hypertonic dextrose versus prolozone (intraarticular ozone) in patients with knee osteoarthritis. Anesth Pain Med. 5(5). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644302/.
Phend, C. (2009). Ozone shots as fffective as surgery for back pain. Medpage Today. Retrieved from https://www.medpagetoday.com/MeetingCoverage/SIR/13206.
Osteopathic Manipulation
Andersson, G., Lucente, T., Davis, A., Kappler, R., Lipton, J., & Leurgans, S. (1999). A Comparison of Osteopathic Spinal Manipulation with Standard Care for Patients with Low Back Pain. The New England Journal of Medicine, 341, 1426-1431.
Bonakdar, R. A. & Sukiennik, A. (2016). Integrative Pain Management. New York, NY: Oxford University Press.
Licciardone, J. C. (2008). The epidemiology and medical management of low back pain during ambulatory medical care visits in the United States.Osteopathic Medicine and Primary Care, 2(1), 1-17.
Ongley, M., Dorman, T., Klein, R., Eek, B., & Hubert, L. (1987). A new approach to the treatment of chronic low back pain. The Lancet, 330(8551), 143-146.
Hyperbaric Oxygen Therapy
Boussi-Gross, R., Golan, H., Fishlev, G., Bechor, Y., Volkov, O., et al. (2013) Hyperbaric Oxygen Therapy Can Improve Post Concussion Syndrome Years after Mild Traumatic Brain Injury – Randomized Prospective Trial. PLoS ONE 8(11): e79995. doi: 10.1371/journal.pone.0079995.
Efrati, S., Fishlev, G., Bechor, Y., Volkov, O., Bergan, J., Kliakhandler, K., … & Golan, H. (2013). Hyperbaric oxygen induces late neuroplasticity in post stroke patients-randomized, prospective trial. PloS one, 8(1), e53716.
Efrati, S., & Ben-Jacob, E. (2014). Reflections on the neurotherapeutic effects of hyperbaric oxygen. Expert review of Neurotherapeutics,14(3), 233-236.
Eve, D. J., Steele, M. R., Sanberg, P. R., & Borlongan, C. V. (2016). Hyperbaric oxygen therapy as a potential treatment for post-traumatic stress disorder associated with traumatic brain injury. Neuropsychiatric disease and treatment, 12, 2689.
Fattori, B., Nacci, A., Casani, A., Donati, C., & De Iaco, G. (2001). [Oxygen therapy in the long term treatment of Meniere’s disease]. Acta otorhinolaryngologica Italica: organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 21(1), 1-9.
Figueroa, X. A., & Wright, J. K. (2016). Hyperbaric oxygen B-level evidence in mild traumatic brain injury clinical trials. Neurology, 87(13), 1400-1406.
Gunther, N. & Queen, E. (2013). What Physical and Cognitive Rest Really Mean After a Concussion. Brainline. Retrieved from https://www.brainline.org/content/multimedia.php?id=9022
Hadanny, A., Abbott, S., Suzin, G., Bechor, Y., & Efrati, S. (2018). Effect of hyperbaric oxygen therapy on chronic neurocognitive deficits of post-traumatic brain injury patients: retrospective analysis. BMJ open, 8(9), e023387.
Hadanny, A., Golan, H., Fishlev, G., Bechor, Y., Volkov, O., Suzin, G., … & Efrati, S. (2015). Hyperbaric oxygen can induce neuroplasticity and improve cognitive functions of patients suffering from anoxic brain damage.Restorative neurology and neuroscience, 33(4), 471-486.
Harch, P. G., Andrews, S. R., Fogarty, E. F., Lucarini, J., & Van Meter, K. W. (2017). Case control study: hyperbaric oxygen treatment of mild traumatic brain injury persistent post-concussion syndrome and post-traumatic stress disorder. Medical Gas Research, 7(3), 156–174. https://doi.org/10.4103/2045-9912.215745
Harch, P. G., Andrews, S. R., Fogarty, E. F., Amen, D., Pezzullo, J. C., Lucarini, J., … & Van Meter, K. W. (2012). A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and post-traumatic stress disorder. Journal of neurotrauma, 29(1), 168-185.
Hardy, P., Johnston, K. M., De Beaumont, L., Montgomery, D. L., Lecomte, J. M., Soucy, J. P., … & Lassonde, M. (2007). Pilot case study of the therapeutic potential of hyperbaric oxygen therapy on chronic brain injury.Journal of the neurological sciences, 253(1), 94-105.
Hu, Q., Manaenko, A., Xu, T., Guo, Z., Tang, J., & Zhang, J. H. (2016). Hyperbaric oxygen therapy for traumatic brain injury: bench-to-bedside. Medical Gas Research, 6(2), 102–110. https://doi.org/10.4103/2045-9912.184720
Hughes, J. (2018). Case Report for a mTBI Patient Treated with Intermittent Home HBOT, Intranasal and IV PRP Cocktail, Intranasal Pluripotent Stem Cells from Peripheral Blood, Intranasal Insulin, Cranial Osteopathy, and a Ketogenic Diet.
Hughes, J. (2016). Case Report for TBI (Traumatic Brain Injury) Patient Treated with A Protocol of HBOT (Hyperbaric Oxygen Therapy), Autologous Human Plasma, Cranial Therapy, EEG Biofeedback, IV Nutrition, and Adult Stem Cells.
Huang, L., & Obenaus, A. (2011). Hyperbaric oxygen therapy for traumatic brain injury. Medical Gas Research, 1, 21. https://doi.org/10.1186/2045-9912-1-21.
Lin, K. C., Niu, K. C., Tsai, K. J., Kuo, J. R., Wang, L. C., Chio, C. C., & Chang, C. P. (2012). Attenuating inflammation but stimulating both angiogenesis and neurogenesis using hyperbaric oxygen in rats with traumatic brain injury. Journal of Trauma and Acute Care Surgery, 72(3), 650-659.
LDN 2019 Conf Cooper Talk retrieved June 14, 2019.
Nourmohammadi, A., Doaee, M., Fazel, A. M., & Mousavi, S. A. (2017). Hyperbaric Oxygen Therapy and Quality of Life: A Systematic Review. Annals of Military and Health Sciences Research, 15(1).
Rockswold, S. B., Rockswold, G. L., Zaun, D. A., Liu, J. (2013). A prospective, randomized Phase II clinical trial to evaluate the effect of combined hyperbaric and normobaric hyperoxia on cerebral metabolism, intracranial pressure, oxygen toxicity, and clinical outcome in severe traumatic brain injury. Journal of Neurosurgery. 8(6):1317-28. doi: 10.3171/2013.2.JNS121468.
Sahni, T., Jain, M., Prasad, R., Sogani, S. K., & Singh, V. P. (2012). Use of hyperbaric oxygen in traumatic brain injury: Retrospective analysis of data of 20 patients treated at a tertiary care centre. British journal of neurosurgery,26(2), 202-207.
Shi, X. Y., Tang, Z. Q., Sun, D., & He, X. J. (2006). Evaluation of hyperbaric oxygen treatment of neuropsychiatric disorders following traumatic brain injury. CHINESE MEDICAL JOURNAL-BEIJING-ENGLISH EDITION-,119(23), 1978.
Stoller, K. P. (2011). # Hyperbaric oxygen therapy (1.5 ATA) in treating sports related TBI/CTE: two case reports. Medical gas research, 1(1), 1-6.
Tal, S., Hadanny, A., Sasson, E., Suzin, G., & Efrati, S. (2017). Hyperbaric oxygen therapy can induce angiogenesis and regeneration of nerve fibers in traumatic brain injury patients. Frontiers in Human Neuroscience, 11, 508.
Tal, S., Hadanny, A., Berkovitz, N., Sasson, E., Ben-Jacob, E., & Efrati, S. (2015). Hyperbaric oxygen may induce angiogenesis in patients suffering from prolonged post-concussion syndrome due to traumatic brain injury. Restorative Neurology and Neuroscience. 33(6):943-51. doi: 10.3233/RNN-150585.
Thom, S. R., Bhopale, V. M., Velazquez, O. C., Goldstein, L. J., Thom, L. H., & Buerk, D. G. (2006). Stem cell mobilization by hyperbaric oxygen. American Journal of Physiology-Heart and Circulatory Physiology, 290(4), H1378-H1386.
Weil, L., Kol, C. P., Sul, K., & Chiu, W. T. (2008). Effect of hyperbaric oxygen on patients with traumatic brain injury. Acta Neurochirurgica Supplements Editor: H.-J. Steiger, 101, 145-149.
WeISS, J. N. (2010). Hyperbaric oxygen therapy and age-related macular degeneration. Undersea & Hyperbaric Medicine, 37(2), 101.
Wolf, G., Cifu, D., Baugh, L., Carne, W., & Profenna, L. (2012). The effect of hyperbaric oxygen on symptoms after mild traumatic brain injury. Journal of neurotrauma, 29(17), 2606-2612.
Wright, J. K., Zant, E., Groom, K., Schlegel, R. E., & Gilliland, K. (2009). Case report: treatment of mild traumatic brain injury with hyperbaric oxygen.
Regenesis
Rapamycin and brain injury: https://scholar.google.com/scholar?q=rapamycin+and+brain+injury&hl=en&as_sdt=0&as_vis=1&oi=scholart
Blagosklonny, M. V. (2023). Cancer prevention with rapamycin. Oncotarget, 14, 342.
Garber K. Rapamycin’s resurrection: A new way to target the cancer cell cycle. J Natl Cancer Inst. 2001;93(20):1517-1519. https://jnci.oxfordjournals.org/content/93/20/1517.fullExit Disclaimer
Hua, H., Kong, Q., Zhang, H., Wang, J., Luo, T., & Jiang, Y. (2019). Targeting mTOR for cancer therapy. Journal of hematology & oncology, 12(1), 1-19.
Jiao Y, Shi C, Edil BH, et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science. 2011;331(6021):1199-1203. [PUBMED Abstract]
Moreno A, Akcakanat A, Munsell MF, Soni A, Yao JC, Meric-Bernstam F. Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors. Endocr Relat Cancer. 2008;15(1):257-266. [PUBMED Abstract]
Thompson LA, Kim M, Wenger SD, O’Bryant CL. Everolimus: A new treatment option for advanced pancreatic neuroendocrine tumors. Ann Pharmacother. 2012;46:1212-1219. [PUBMED Abstract]
Venn-Watson, S., Lumpkin, R. & Dennis, E.A. Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential?. Sci Rep 10, 8161 (2020). https://doi.org/10.1038/s41598-020-64960-y
Contact Aspen
Integrative Medicine
BASALT:
227 Midland Ave, Suite 18B, Basalt, CO 81621
(In the courtyard between Basalt Firearms and Karen White)
Hours: Tuesday & Thursday: 12pm-5pm
Appointment required
ASPEN:
230 S. Mill Street, Aspen, CO 81611
(Above Royal Street Fine Art and Across from Louis Vuitton)
Hours: Monday, Wednesday, Friday: 12pm-5pm
Appointment required